SCHEMBL5637103

SCHEMBL5637103

S=C1CC=CC=C1c1nc(Br)cs1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5637279 0.78
SCHEMBL9095268 0.70 PDPK1 (0.35)
SCHEMBL11600094 0.70
SCHEMBL586988 0.67 CYP19A1 (0.34)
SCHEMBL3072251 0.67
SCHEMBL3062201 0.66
SCHEMBL8066255 0.64 RAB9A (0.44)
SCHEMBL10446539 0.62 ALDH1A1 (0.32)
SCHEMBL3066035 0.62
SCHEMBL5884963 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7173137-B2 Epothilone analogs THE SCRIPPS RESEARCH INSTITUTE (US) 2007-02-06 US disclosed
US-20040127432-A1 Epothilone analogs THE SCRIPPS RESEARCH INSTITUTE 2004-07-01 US disclosed
US-6660758-B1 Prevention of mitosis; induction and stabilization of microtubules THE SCRIPPS RESEARCH INSTITUTE 2003-12-09 US disclosed
US-6441186-B1 ANTICANCER AGENTS; PREVENTION OF MITOSIS THROUGH INDUCTION AND STABILIZATION OF MICROTUBULIN ASSEMBLY; SUPERIOR CYTOTOXIC ACTIVITIES THE SCRIPPS RESEARCH INSTITUTE 2002-08-27 US disclosed
EP-0944634-A1 EPOTHILONE ANALOGS Novartis AG (CH) 1999-09-29 EP disclosed
WO-1998025929-A1 EPOTHILONE ANALOGS NOVARTIS AG (CH) 1998-06-18 WO disclosed